ewizabeth wrote:BTW, he thinks Cladribine will still be approved in 2010 but maybe not as soon as he had hoped.
Lyon wrote:I've never mentioned it to anyone but if Jamie's MS progressed, Cladribine is what I'm most interested in of the options to be available in the near future.
Her neuro in the Tovaxin clinical trial was trained by Kurtzke at Georgetown and the first thing she told us, almost seemed to be bragging, was that, of her patients on Copaxone she had never had one progress to the wheelchair. That always seemed impressive for some reason. I should have asked her what the hell it meant exactly.
Users browsing this forum: No registered users